262 related articles for article (PubMed ID: 10600838)
21. Widespread expression of ErbB2, ErbB3 and ErbB4 in non-human primate brain.
Thompson M; Lauderdale S; Webster MJ; Chong VZ; McClintock B; Saunders R; Weickert CS
Brain Res; 2007 Mar; 1139():95-109. PubMed ID: 17280647
[TBL] [Abstract][Full Text] [Related]
22. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.
Petit AM; Rak J; Hung MC; Rockwell P; Goldstein N; Fendly B; Kerbel RS
Am J Pathol; 1997 Dec; 151(6):1523-30. PubMed ID: 9403702
[TBL] [Abstract][Full Text] [Related]
23. Antagonistic effect of NK4, a novel hepatocyte growth factor variant, on in vitro angiogenesis of human vascular endothelial cells.
Jiang WG; Hiscox SE; Parr C; Martin TA; Matsumoto K; Nakamura T; Mansel RE
Clin Cancer Res; 1999 Nov; 5(11):3695-703. PubMed ID: 10589789
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of ERBB family mRNA expression in breast carcinomas.
Bièche I; Onody P; Tozlu S; Driouch K; Vidaud M; Lidereau R
Int J Cancer; 2003 Sep; 106(5):758-65. PubMed ID: 12866037
[TBL] [Abstract][Full Text] [Related]
25. Vascular endothelial growth factor-toxin conjugate specifically inhibits KDR/flk-1-positive endothelial cell proliferation in vitro and angiogenesis in vivo.
Ramakrishnan S; Olson TA; Bautch VL; Mohanraj D
Cancer Res; 1996 Mar; 56(6):1324-30. PubMed ID: 8640821
[TBL] [Abstract][Full Text] [Related]
26. Role of neuregulin-1 beta in the developing lung.
Dammann CE; Nielsen HC; Carraway KL
Am J Respir Crit Care Med; 2003 Jun; 167(12):1711-6. PubMed ID: 12663324
[TBL] [Abstract][Full Text] [Related]
27. Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF.
Jia H; Jezequel S; Löhr M; Shaikh S; Davis D; Soker S; Selwood D; Zachary I
Biochem Biophys Res Commun; 2001 Apr; 283(1):164-73. PubMed ID: 11322784
[TBL] [Abstract][Full Text] [Related]
28. Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide.
Bussolati B; Dunk C; Grohman M; Kontos CD; Mason J; Ahmed A
Am J Pathol; 2001 Sep; 159(3):993-1008. PubMed ID: 11549592
[TBL] [Abstract][Full Text] [Related]
29. ErbB transmembrane tyrosine kinase receptors are differentially expressed throughout the adult rat central nervous system.
Gerecke KM; Wyss JM; Karavanova I; Buonanno A; Carroll SL
J Comp Neurol; 2001 Apr; 433(1):86-100. PubMed ID: 11283951
[TBL] [Abstract][Full Text] [Related]
30. Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors.
Alimandi M; Wang LM; Bottaro D; Lee CC; Kuo A; Frankel M; Fedi P; Tang C; Lippman M; Pierce JH
EMBO J; 1997 Sep; 16(18):5608-17. PubMed ID: 9312020
[TBL] [Abstract][Full Text] [Related]
31. Biological response to ErbB ligands in nontransformed cell lines correlates with a specific pattern of receptor expression.
Sundaresan S; Roberts PE; King KL; Sliwkowski MX; Mather JP
Endocrinology; 1998 Dec; 139(12):4756-64. PubMed ID: 9832411
[TBL] [Abstract][Full Text] [Related]
32. Normal female sexual development requires neuregulin-erbB receptor signaling in hypothalamic astrocytes.
Prevot V; Rio C; Cho GJ; Lomniczi A; Heger S; Neville CM; Rosenthal NA; Ojeda SR; Corfas G
J Neurosci; 2003 Jan; 23(1):230-9. PubMed ID: 12514220
[TBL] [Abstract][Full Text] [Related]
33. The ErbB2 and ErbB3 receptors and their ligand, neuregulin-1, are essential for development of the sympathetic nervous system.
Britsch S; Li L; Kirchhoff S; Theuring F; Brinkmann V; Birchmeier C; Riethmacher D
Genes Dev; 1998 Jun; 12(12):1825-36. PubMed ID: 9637684
[TBL] [Abstract][Full Text] [Related]
34. An RBCC protein implicated in maintenance of steady-state neuregulin receptor levels.
Diamonti AJ; Guy PM; Ivanof C; Wong K; Sweeney C; Carraway KL
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2866-71. PubMed ID: 11867753
[TBL] [Abstract][Full Text] [Related]
35. Vascular permeability factor/vascular endothelial growth factor-mediated signaling in mouse mesentery vascular endothelium.
Mukhopadhyay D; Nagy JA; Manseau EJ; Dvorak HF
Cancer Res; 1998 Mar; 58(6):1278-84. PubMed ID: 9515816
[TBL] [Abstract][Full Text] [Related]
36. Heregulin-beta is especially potent in activating phosphatidylinositol 3-kinase in nontransformed human mammary epithelial cells.
Ram TG; Hosick HL; Ethier SP
J Cell Physiol; 2000 Jun; 183(3):301-13. PubMed ID: 10797304
[TBL] [Abstract][Full Text] [Related]
37. Activation of ErbB2 by overexpression or by transmembrane neuregulin results in differential signaling and sensitivity to herceptin.
Yuste L; Montero JC; Esparís-Ogando A; Pandiella A
Cancer Res; 2005 Aug; 65(15):6801-10. PubMed ID: 16061662
[TBL] [Abstract][Full Text] [Related]
38. Possible involvement of VEGF-FLT tyrosine kinase receptor system in normal and tumor angiogenesis.
Shibuya M; Seetharam L; Ishii Y; Sawano A; Gotoh N; Matsushime H; Yamaguchi S
Princess Takamatsu Symp; 1994; 24():162-70. PubMed ID: 8983073
[TBL] [Abstract][Full Text] [Related]
39. Regulation of neuregulin/ErbB signaling by contractile activity in skeletal muscle.
Lebrasseur NK; Coté GM; Miller TA; Fielding RA; Sawyer DB
Am J Physiol Cell Physiol; 2003 May; 284(5):C1149-55. PubMed ID: 12519750
[TBL] [Abstract][Full Text] [Related]
40. All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired.
Baulida J; Kraus MH; Alimandi M; Di Fiore PP; Carpenter G
J Biol Chem; 1996 Mar; 271(9):5251-7. PubMed ID: 8617810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
